Cargando…

Endothelial Protein C Receptor (EPCR), Protease Activated Receptor-1 (PAR-1) and Their Interplay in Cancer Growth and Metastatic Dissemination

Endothelial protein C receptor (EPCR) and protease activated receptor 1 (PAR-1) by themselves play important role in cancer growth and dissemination. Moreover, interactions between the two receptors are essential for tumor progression. EPCR is a cell surface transmembrane glycoprotein localized pred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wojtukiewicz, Marek Z., Hempel, Dominika, Sierko, Ewa, Tucker, Stephanie C., Honn, Kenneth V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356956/ https://www.ncbi.nlm.nih.gov/pubmed/30626007 http://dx.doi.org/10.3390/cancers11010051

Ejemplares similares

Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2015)

Comment on “Endothelial Protein C Receptor (EPCR), Protease Activated Receptor-1 (PAR-1) and Their Interplay in Cancer Growth and Metastatic Dissemination” Cancers 2019, 11, 51
por: Pontarollo, Giulia, et al.
Publicado: (2019)

Platelets and cancer angiogenesis nexus
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2017)

Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2017)

Personalized Radiation Therapy in Cancer Pain Management
por: Sierko, Ewa, et al.
Publicado: (2019)

The APC-EPCR-PAR1 axis in sickle cell disease
por: Ramadas, Nirupama, et al.
Publicado: (2023)

Elevated Microparticles, Thrombin-antithrombin and VEGF Levels in Colorectal Cancer Patients Undergoing Chemotherapy
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2020)

Protein Z/protein Z-dependent protease inhibitor system in loco in human gastric cancer
por: Sierko, Ewa, et al.
Publicado: (2013)

EPCR-PAR1 biased signaling regulates perfusion recovery and neovascularization in peripheral ischemia
por: Bochenek, Magdalena L., et al.
Publicado: (2022)

Haplotypes of the endothelial protein C receptor (EPCR) gene are not associated with severe malaria in Tanzania
por: Hansson, Helle Holm, et al.
Publicado: (2015)

Identification of a broad lipid repertoire associated to the endothelial cell protein C receptor (EPCR)
por: Erausquin, Elena, et al.
Publicado: (2022)

Histone 2B Facilitates Plasminogen-Enhanced Endothelial Migration through Protease-Activated Receptor 1 (PAR1) and Protease-Activated Receptor 2 (PAR2)
por: Das, Mitali, et al.
Publicado: (2022)

Chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question?
por: Sawicka, Emilia, et al.
Publicado: (2016)

Endothelial microparticles released by activated protein C protect beta cells through EPCR/PAR1 and annexin A1/FPR2 pathways in islets
por: Kreutter, Guillaume, et al.
Publicado: (2017)

Endothelial Protein C Receptor gene Expression in a Female with Homozygous EPCR gene 23-bp Insertion
por: Karabıyık, Afife, et al.
Publicado: (2012)

The Effects of Endothelial Protein C Receptor Gene Polymorphisms on the Plasma sEPCR Level in Venous Thrombosis Patients
por: Karabıyık, Afife, et al.
Publicado: (2012)

Endothelial Protease Activated Receptor 1 (PAR1) Signalling Is Required for Lymphocyte Transmigration across Brain Microvascular Endothelial Cells
por: Dragoni, Silvia, et al.
Publicado: (2020)

Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis
por: Lin, Cong, et al.
Publicado: (2015)

Protease-activated receptor-1 (PAR1) promotes epithelial-endothelial transition through Twist1 in hepatocellular carcinoma
por: Xiao, Ting, et al.
Publicado: (2018)

The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease
por: Nilsen, Dennis W. T., et al.
Publicado: (2022)

Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2021)

Soluble endothelial protein C receptor (sEPCR) is likely a biomarker of cancer-associated hypercoagulability in human hematologic malignancies
por: Ducros, Elodie, et al.
Publicado: (2012)

Actual, Personalized Approaches to Preserve Cognitive Functions in Brain Metastases Breast Cancer Patients
por: Konopka-Filippow, Monika, et al.
Publicado: (2022)

Direct Oral Anticoagulants in Cancer Patients. Time for a Change in Paradigm
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2020)

The H3 Haplotype of the EPCR Gene Determines High sEPCR Levels in Critically Ill Septic Patients
por: Vassiliou, Alice G., et al.
Publicado: (2018)

Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer
por: Liu, Xuan, et al.
Publicado: (2017)

Role of protease‐activated receptor‐1 (PAR‐1) in the glomerular filtration barrier integrity
por: Medipally, Ajay, et al.
Publicado: (2022)

The endothelial protein C receptor rs867186-GG genotype is associated with increased soluble EPCR and could mediate protection against severe malaria
por: Shabani, Estela, et al.
Publicado: (2016)

Is There an Interplay between Oral Microbiome, Head and Neck Carcinoma and Radiation-Induced Oral Mucositis?
por: Gugnacki, Patryk, et al.
Publicado: (2021)

Developmental Role of Zebrafish Protease-Activated Receptor 1 (PAR1) in the Cardio-Vascular System
por: Ellertsdottir, Elin, et al.
Publicado: (2012)

Heterogeneous Expression of Proangiogenic and Coagulation Proteins in Gliomas of Different Histopathological Grade
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2021)

Imbalance in Coagulation/Fibrinolysis Inhibitors Resulting in Extravascular Thrombin Generation in Gliomas of Varying Levels of Malignancy
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2021)

Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets
por: French, Shauna L., et al.
Publicado: (2016)

An ADAM-10 dependent EPCR shedding links meningococcal interaction with endothelial cells to purpura fulminans
por: Lécuyer, Hervé, et al.
Publicado: (2018)

Complement factor C4a does not activate protease‐activated receptor 1 (PAR1) or PAR4 on human platelets
por: Han, Xu, et al.
Publicado: (2020)

Protease activated receptor 1 (PAR1) enhances Src-mediated tyrosine phosphorylation of NMDA receptor in intracerebral hemorrhage (ICH)
por: Duan, Zhen-Zhen, et al.
Publicado: (2016)

Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma
por: Tas, Faruk, et al.
Publicado: (2016)

Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation
por: Friebel, Julian, et al.
Publicado: (2021)

EPCR promotes MGC803 human gastric cancer cell tumor angiogenesis in vitro through activating ERK1/2 and AKT in a PAR1-dependent manner
por: Wang, Qingling, et al.
Publicado: (2018)

Platelet Specific Promoters Are Insufficient to Express Protease Activated Receptor 1 (PAR1) Transgene in Mouse Platelets
por: Arachiche, Amal, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_83icusjmgmj1b5d43kn4ddvvr1